Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 0.593 Delayed Data As of 4:09pm ET |  +0.041 / +7.43%Today’s Change | 0.38 Today|||52-Week Range 1.14 | -34.13% Year-to-Date |
| Previous close | 0.55 |
| Today’s open | 0.56 |
| Day’s range | 0.56 - 0.60 |
| Volume | 367,150 |
| Average volume (3 months) | 406,516 |
| Market cap | $37.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +41.94% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| NTRPNeurotrope Inc | +0.11 | +1.99% |
| ZSANZosano Pharma Corp | +0.04 | +4.33% |
| PTXPernix Therapeutics ... | +0.02 | +0.69% |
| PPHMPPeregrine Pharmaceut... | -0.12 | -0.55% |
| Last reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Financial Officer & Controller Thomas E. Chilcott |
Corporate headquarters Englewood, Colorado |
